CHONDROITIN SULFATE MARKET ANALYSIS

Regional Analysis

Global Chondroitin Sulfate Market: Regional Insights

Based on geography, the global chondroitin sulfate market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Regionally, North America is expected to dominate the global chondroitin sulfate market over the forecast period owing to the booming pharmaceutical industry along with the FDA approval for including chondroitin sulfate infused in dietary products. Also, increasing prevalence of osteoarthritis is again expected to fuel regional market growth. Centers for Disease Control and Prevention estimates that 1 in 4 (or 54.4 million) US adults have some form of arthritis, a figure that is expected to reach 78 million by the year 2040.1 While there are estimated to be more than 100 types of arthritis, osteoarthritis (OA) is the most common form of arthritis, affecting 32.5 million US adults.

Europe is a second leading region for global chondroitin sulfate market. This is attributed to the growing demand from cosmetics, pharmaceutical, food, pet food, and veterinary applications. Moreover, Chondroitin sulfate is approved and regulated as a symptomatic slow-acting drug for osteoarthritis (SySADOA) in Europe and its intake is preferred along with glucosamine.

• North America: U.S. and Canada
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Central and South America: Brazil, Argentina, Mexico, and Rest of Latin America
• Middle East: GCC Countries, Israel,  South Africa, North Africa
• Africa: Central Africa and Rest of Middle East